Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel
Chronic hepatitis C (HCV) infection is currently one of the most clinically relevant
comorbidities in the HIV population; overall, it affects one third of HIV-positive individuals [1] …
comorbidities in the HIV population; overall, it affects one third of HIV-positive individuals [1] …
Viral hepatitis and HIV co-infection
Chronic hepatitis B virus (HBV) infection is overall recognised in 10% of HIV+ persons
worldwide, with large differences according to geographical region. Chronic hepatitis C virus …
worldwide, with large differences according to geographical region. Chronic hepatitis C virus …
Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus—Infected Patients with Chronic Hepatitis C: A European Collaborative Study
L Martín-Carbonero, Y Benhamou… - Clinical Infectious …, 2004 - academic.oup.com
A study was performed in 10 European health care centers in which 914 patients coinfected
with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) who had elevated …
with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) who had elevated …
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients
NI Rallón, S Naggie, JM Benito, J Medrano, C Restrepo… - Aids, 2010 - journals.lww.com
Background: Given that peginterferon–ribavirin treatment is poorly tolerated, there is interest
in the identification of predictors of response, particularly in HIV/hepatitis C virus (HCV) …
in the identification of predictors of response, particularly in HIV/hepatitis C virus (HCV) …
Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients
P Labarga, V Soriano, ME Vispo, J Pinilla… - The Journal of …, 2007 - academic.oup.com
Background. The risk of liver toxicity during antiretroviral drug use in human
immunodeficiency virus (HIV)-positive patients increases in the presence of chronic hepatitis …
immunodeficiency virus (HIV)-positive patients increases in the presence of chronic hepatitis …
Liver cirrhosis in HIV‐infected patients: prevalence, aetiology and clinical outcome
C Castellares, P Barreiro… - Journal of viral …, 2008 - Wiley Online Library
Liver disease is frequently seen in HIV+ patients as a result of coinfection with hepatitis B
(HBV) or C (HCV) viruses, alcohol abuse and/or exposure to hepatotoxic drugs. The aim of …
(HBV) or C (HCV) viruses, alcohol abuse and/or exposure to hepatotoxic drugs. The aim of …
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
Background: Increases in deaths due to liver-related disease (LRD) among HIV-infected
individuals have been reported although the influence of combination antiretroviral therapy …
individuals have been reported although the influence of combination antiretroviral therapy …
Management of chronic hepatitis B and C in HIV-coinfected patients
One-third of HIV-infected individuals worldwide suffer from chronic hepatitis C virus (HCV)
infection, but chronic hepatitis C affects more than 75% of HIV-positive subjects infected …
infection, but chronic hepatitis C affects more than 75% of HIV-positive subjects infected …
Liver fibrosis on account of chronic hepatitis C is more severe in HIV‐positive than HIV‐negative patients despite antiretroviral therapy
V De Ledinghen, P Barreiro, J Foucher… - Journal of viral …, 2008 - Wiley Online Library
The recent availability of non‐invasive tools to measure liver fibrosis has allowed
examination of its extent and determination of predictors in all patients with chronic hepatitis …
examination of its extent and determination of predictors in all patients with chronic hepatitis …
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
Background There is little information about the influence of antiretroviral drugs on the
antiviral activity of pegylated interferon (PEG-IFN) plus ribavirin (RBV) against hepatitis C …
antiviral activity of pegylated interferon (PEG-IFN) plus ribavirin (RBV) against hepatitis C …